MTOR and autoimmune polyendocrinopathy: Furthermore, in vitro studies have shown that treatment of anti-β2GPI/β2GPI or APS-IgG/β2GPI complex could markedly induce mTOR activation as well as expression of TF and IL-8 in THP-1 cells (a human monocytic cell line) or primary monocytes.